Brian J. Gates

500 total citations
28 papers, 369 citations indexed

About

Brian J. Gates is a scholar working on Geriatrics and Gerontology, Family Practice and Pharmacology. According to data from OpenAlex, Brian J. Gates has authored 28 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 7 papers in Family Practice and 6 papers in Pharmacology. Recurrent topics in Brian J. Gates's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Medication Adherence and Compliance (7 papers) and Inflammatory mediators and NSAID effects (5 papers). Brian J. Gates is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Medication Adherence and Compliance (7 papers) and Inflammatory mediators and NSAID effects (5 papers). Brian J. Gates collaborates with scholars based in United States, United Kingdom and Switzerland. Brian J. Gates's co-authors include Stephen M. Setter, Neal M. Davies, Joshua J. Neumiller, Cynthia F. Corbett, David A. Sclar, Shyamal Kumar Das, Terri Levien, Cynthia F. Corbett, Katherine R. Tuttle and R. Keith Campbell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Journal of the American Society of Nephrology and Injury.

In The Last Decade

Brian J. Gates

27 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian J. Gates United States 10 107 51 49 47 43 28 369
Kimberly Braxton Lloyd United States 12 130 1.2× 34 0.7× 74 1.5× 32 0.7× 25 0.6× 25 370
Katrin Farker Germany 10 134 1.3× 75 1.5× 28 0.6× 104 2.2× 26 0.6× 31 483
TJ White United States 6 113 1.1× 76 1.5× 121 2.5× 47 1.0× 146 3.4× 10 434
Supriya Malhotra India 10 139 1.3× 33 0.6× 48 1.0× 45 1.0× 51 1.2× 65 469
Osama Y. Alshogran Jordan 12 55 0.5× 52 1.0× 17 0.3× 23 0.5× 40 0.9× 59 465
Mandy C. Leonard United States 10 144 1.3× 59 1.2× 24 0.5× 32 0.7× 13 0.3× 19 439
Kerry Mansell Canada 12 134 1.3× 42 0.8× 61 1.2× 23 0.5× 150 3.5× 42 461
Jacqueline S. Marinac United States 11 96 0.9× 20 0.4× 14 0.3× 74 1.6× 34 0.8× 17 429
Balázs Hankó Hungary 7 39 0.4× 15 0.3× 30 0.6× 34 0.7× 49 1.1× 23 204
Teresa Bailey Klepser United States 9 37 0.3× 75 1.5× 10 0.2× 76 1.6× 66 1.5× 12 523

Countries citing papers authored by Brian J. Gates

Since Specialization
Citations

This map shows the geographic impact of Brian J. Gates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian J. Gates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian J. Gates more than expected).

Fields of papers citing papers by Brian J. Gates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian J. Gates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian J. Gates. The network helps show where Brian J. Gates may publish in the future.

Co-authorship network of co-authors of Brian J. Gates

This figure shows the co-authorship network connecting the top 25 collaborators of Brian J. Gates. A scholar is included among the top collaborators of Brian J. Gates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian J. Gates. Brian J. Gates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gates, Brian J., et al.. (2021). Teaching transgender patient care to student pharmacists. Currents in Pharmacy Teaching and Learning. 13(12). 1611–1618. 9 indexed citations
2.
Baker, Danial E., et al.. (2020). Newly Approved Novel Dosage Forms of Glucagon for Management of Severe Hypoglycemia. The Senior Care Pharmacist. 35(4). 176–181.
3.
Clark, Jeffrey A., et al.. (2020). Medication Regimen Complexity in Patients Receiving Consultant Pharmacy Services in Home Health Care. The Senior Care Pharmacist. 35(2). 81–84. 2 indexed citations
4.
Neumiller, Joshua J., et al.. (2019). Potential Adverse Drug Events and Associated Costs During Transition from Hospital to Home. The Senior Care Pharmacist. 34(6). 384–392. 6 indexed citations
5.
Clark, Jeffrey A., Brian J. Gates, Kimberly C. McKeirnan, & David A. Sclar. (2016). Assessed Value of Consultant Pharmacist Services in a Home Health Care Agency. The Consultant Pharmacist. 31(3). 161–167. 5 indexed citations
6.
Alicic, Radica Z., Robert Short, Cynthia F. Corbett, et al.. (2016). Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics. American Journal of Nephrology. 44(2). 122–129. 11 indexed citations
7.
Gates, Brian J., et al.. (2014). Cognitive and Literacy Screening as Predictors of Ability to Fill a Pillbox Using Two Pillbox Assessment Scoring Methods. The Consultant Pharmacist. 29(5). 304–316. 8 indexed citations
8.
Gates, Brian J., et al.. (2014). Physiological Changes in Older Adults and Their Effect on Diabetes Treatment. Diabetes Spectrum. 27(1). 20–29. 12 indexed citations
9.
Corbett, Cynthia F., et al.. (2012). Clinical Significance as It Relates to Evidence-Based Practice. International Journal of Nursing Knowledge. 23(2). 62–74. 6 indexed citations
10.
Gates, Brian J. & Shyamal Kumar Das. (2011). Management of osteoporosis in elderly men. Maturitas. 69(2). 113–119. 13 indexed citations
11.
Levien, Terri, et al.. (2010). Diabetes Mellitus, Inflammation, Obesity: Proposed Treatment Pathways for Current and Future Therapies. Annals of Pharmacotherapy. 44(4). 701–711. 20 indexed citations
12.
Neumiller, Joshua J., et al.. (2009). <b>Pharmacological Management of Glycemic Control in the Geriatric Patient with Type 2 Diabetes Mellitus</b>. The Consultant Pharmacist. 24(1). 45–63. 7 indexed citations
13.
Levien, Terri, et al.. (2009). Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus. Clinical Therapeutics. 31(2). 245–259. 18 indexed citations
14.
Gates, Brian J., et al.. (2009). Review of osteoporosis pharmacotherapy for geriatric patients. ˜The œAmerican journal of geriatric pharmacotherapy. 7(6). 293–323. 36 indexed citations
15.
Setter, Stephen M., et al.. (2009). Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care. American Journal of Health-System Pharmacy. 66(22). 2027–2031. 52 indexed citations
16.
Davies, Neal M., et al.. (2006). Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal. Expert Review of Neurotherapeutics. 6(11). 1643–1655. 23 indexed citations
17.
Gates, Brian J. & Neal M. Davies. (2006). AmpliChip for Cytochrome P-450 Genotyping: The Epoch of Personalized Prescriptions. Hospital Pharmacy. 41(5). 442–454. 2 indexed citations
18.
Gates, Brian J., et al.. (2005). Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety. Expert Opinion on Pharmacotherapy. 6(12). 2117–2140. 69 indexed citations
19.
Setter, Stephen M., et al.. (2001). Nonsteroidal anti-inflammatory drugs: The need for assessment and education. Home Care Provider. 6(3). 100–105. 4 indexed citations
20.
Setter, Stephen M., Cynthia F. Corbett, David A. Sclar, Brian J. Gates, & Steven B. Johnson. (2001). Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Research to Help Your Patients Use them Safely. Home Health Care Management & Practice. 13(6). 468–475. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026